Skip to main content
Screener/Healthcare/Biotechnology

BMRN — BioMarin Pharmaceutical Inc.

NASDAQ
$53.96-0.14 (-0.26%)
Large CapHealthcareLow Beta
$50.76
$66.28
$53.53
$54.55
EPS (TTM)$1.80
P/E Ratio29.98
Dividend Yield—
Market Cap$10.41B
Volume1.31M
Prev Close$54.12
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$874.6M-$46.6M$-0.2266.3%-5.3%
Q3 '25$776.1M-$30.7M$-0.1682.0%-4.0%
Q2 '25$825.4M$240.5M$1.2381.8%29.1%
Q1 '25$745.1M$185.7M$0.9579.7%24.9%
Q4 '24$747.3M$124.9M$0.6481.8%16.7%
Q3 '24$745.7M$106.1M$0.5574.7%14.2%
Q2 '24$712.0M$107.2M$0.5581.7%15.1%
Q1 '24$648.8M$88.7M$0.4680.7%13.7%
Get Your Daily Market Recap
BMRN Stock Price, Chart & Analysis